COPD Flashcards
symptoms of copd
wheezing
persistent cough
sputum production
infective exacerbations
what are the components of copd
Small airway disease
emphysema
chronic bronchitis
common causes
smoking
air pollution
chest infection
nutrition
genetics
what is the multi component process
- The 3 main processes that are happening are mucociliary dysfunction, inflammation and tissue damage
- Each one exacerbates condition of the other
- Combination of three leads to obstruction of airway
- Leads to characteristics of disease e.g. exacerbations
what is chronic bronchitis
exposure to harmful chemicals leads to excessive mucus.
hypertrophy increase in size of submucosal glands increased mucus production
increase in goblets cells more mucus
what is the natural cause of copd
1) Initial breathlessness (dyspnoea) during exercise but then later during rest
2) Cough and sputum production mainly in the morning but later all day
3) Acute respiratory infections occurring frequently, mostly in the winter with exacerbation of symptoms
4) Hypoxia initially in exercise, but then later during sleep and at rets during the day, leading to pulmonary hypertension
5) Chronic respiratory failure, right ventricular heart disease
6) Then terminal acute respiratory failure
what are the treatment goals of copd
prevent exacerbation
prevent disease progression
relieve symptoms
improve QOL
how to prevent smoking in copd
nictoine replacement i.e gum inhaler
bupropion a nicotinic ach receptor agonist
moa of anticholinergics
1) Release of Ach from vagus nerves
2) Some Ach goes and binds to M3 receptor causing contraction
3) Some of Ach binds to M2 on presynaptic terminal of vagus nerves inhibiting further release of ach (negative feedback loop)
In COPD
1) Narrowing of lumen in airways due to inflammation
2) Release of Ach from vagus nerves, binds to M3 receptor . causing more narrowing of lumen as it constricts muscles, restricting airways
3) Anticholinergics block receptors, by binding to receptors
4) Prevents Ach from binding to receptors, Ach removed, no muscle contraction, airway open.
moa of rumiflast
- When cAMP produced its broken down to amp by phosphodiesterase type 4 enzyme
- Roflumilast inhibits phosphodiesterase 4, meaning breakdown of cAMP is blocked so cAMP accumulates
- Increase in cAMP in cells improves tissue remodelling by inhibiting fibroblast and inhibiting inflammatory pathways
- Negative pathways restored in normal function with roflumilast
first line treatment of copd
offer a SABA or SAMA to relieve breathlessness associated with activities. For example - Salbutamol 100 micrograms (DPI where possible, use in-check dial to decide) 2 puffs PRN or Ipratropium bromide (MDI) 2puffs QDSPRN.
what are the lines of treatment of copd
- vaccination
- add bronchodilator ( salbutamol or ipratropium)
- add LABA ( salmeterol or tiotropium)
- add roflumilast
- add pxygen therapy